Date published: 2026-4-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

ZNF8 Inhibitors

ZNF8 inhibitors are a class of chemical agents specifically designed to modulate the activity of the ZNF8 protein, which is part of the broader family of zinc finger proteins. Zinc finger proteins are characterized by their finger-like protrusions that bind zinc ions, playing a pivotal role in DNA binding, RNA transcription, and protein-protein interactions. The ZNF8 protein, in particular, contains these zinc finger motifs that allow it to interact with DNA and possibly other proteins. The inhibitors targeting ZNF8 are specialized molecules that can interact with the ZNF8 protein to alter its biological activity. The design and discovery of ZNF8 inhibitors involve an intricate understanding of the protein's structure, the specific zinc finger domains it contains, and the precise manner in which it interacts with other molecular entities in the cell.

Creating inhibitors for ZNF8 entails identifying the active or binding sites on the protein that are critical for its function. Researchers employ a variety of techniques, such as computational biology, to predict how small molecules might interact with the ZNF8 protein. Advanced analytical methods, including X-ray crystallography or NMR spectroscopy, are often used to determine the three-dimensional structure of ZNF8, identifying potential grooves or pockets where an inhibitor could bind. The binding of an inhibitor to ZNF8 can inhibit its function by preventing the protein from interacting with DNA or other proteins required for its normal activity. The specificity of these inhibitors is crucial to ensure that they do not interfere with other zinc finger proteins that have distinct and essential roles in cellular processes. Developing inhibitors with high specificity requires detailed knowledge of the differences in the structure and binding preferences between ZNF8 and other zinc finger proteins. The intricate process of designing ZNF8 inhibitors is a testament to the sophisticated nature of molecular interaction and the precision required to affect specific protein functions without unintended consequences.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

5-Aza-2′-Deoxycytidine

2353-33-5sc-202424
sc-202424A
sc-202424B
25 mg
100 mg
250 mg
$218.00
$322.00
$426.00
7
(1)

Decitabine is a DNA methyltransferase inhibitor which may demethylate DNA and reactivate silenced genes, potentially altering the expression of various proteins including transcription factors.

Suberoylanilide Hydroxamic Acid

149647-78-9sc-220139
sc-220139A
100 mg
500 mg
$133.00
$275.00
37
(2)

SAHA is a histone deacetylase inhibitor which may cause hyperacetylation of histone proteins, leading to a more open chromatin structure and potentially altered gene expression.

Etoposide (VP-16)

33419-42-0sc-3512B
sc-3512
sc-3512A
10 mg
100 mg
500 mg
$51.00
$231.00
$523.00
63
(1)

Etoposide interferes with DNA replication by inhibiting topoisomerase II, which could result in DNA damage and potentially affect transcription factor availability and gene expression.

Taxol

33069-62-4sc-201439D
sc-201439
sc-201439A
sc-201439E
sc-201439B
sc-201439C
1 mg
5 mg
25 mg
100 mg
250 mg
1 g
$41.00
$74.00
$221.00
$247.00
$738.00
$1220.00
39
(2)

Paclitaxel stabilizes microtubules and can arrest cell division, which might indirectly reduce the expression of certain proteins by halting cell cycle progression.

(±)-JQ1

1268524-69-1sc-472932
sc-472932A
5 mg
25 mg
$231.00
$863.00
1
(0)

JQ1 inhibits the BET family of bromodomain proteins, potentially altering the expression of genes regulated by these epigenetic readers.

Tunicamycin

11089-65-9sc-3506A
sc-3506
5 mg
10 mg
$172.00
$305.00
66
(3)

Tunicamycin inhibits N-linked glycosylation, which can disrupt protein folding and stability, potentially reducing protein levels.

Bortezomib

179324-69-7sc-217785
sc-217785A
2.5 mg
25 mg
$135.00
$1085.00
115
(2)

Bortezomib is a proteasome inhibitor that can prevent the degradation of ubiquitinated proteins, potentially affecting the levels of regulatory proteins that control gene expression.

Sorafenib

284461-73-0sc-220125
sc-220125A
sc-220125B
5 mg
50 mg
500 mg
$57.00
$100.00
$250.00
129
(3)

Sorafenib is a kinase inhibitor that may affect various signaling pathways, potentially altering the transcriptional regulation of numerous genes.

Nutlin-3

548472-68-0sc-45061
sc-45061A
sc-45061B
1 mg
5 mg
25 mg
$62.00
$225.00
$779.00
24
(1)

Nutlin-3 antagonizes MDM2, potentially stabilizing p53 and affecting the expression of p53-regulated genes.

Retinoic Acid, all trans

302-79-4sc-200898
sc-200898A
sc-200898B
sc-200898C
500 mg
5 g
10 g
100 g
$66.00
$325.00
$587.00
$1018.00
28
(1)

Retinoic acid is a metabolite of vitamin A, which can regulate gene expression by activating nuclear hormone receptors.